Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polysialogangliosides are a class of sialic acid-containing glycosphingolipids that are highly concentrated within the presynaptic membranes of the nervous system (Schengrund, 2015). They function as essential co-receptors for clostridial neurotoxins, such as Botulinum and Tetanus toxins, by mediating the initial high-affinity binding required for toxin internalization into neurons (Rummel, 2016). Beyond their role in toxin entry, these molecules are critical for maintaining synaptic integrity, modulating the activity of ion channels, and facilitating cell-to-cell recognition and signaling (Schnaar, 2016). In clinical medicine, they are the functional targets for therapeutic Botulinum neurotoxins used to treat conditions like muscle spasticity, dystonia, and chronic migraine (Pirazzini et al., 2017). Furthermore, polysialogangliosides are significant in the pathogenesis of autoimmune neuropathies, such as Guillain-Barré and Miller Fisher syndromes, where they are targeted by autoantibodies (Willison et al., 2016). Understanding their distribution and binding kinetics is vital for the development of next-generation neurotherapeutics and antitoxins.
Acts as a high-affinity binding site for the heavy chain of clostridial neurotoxins, facilitating their entry into the nerve terminal via a dual-receptor mediated endocytosis process.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polysialoganglioside (PSG).